Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

726
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
726
Neural Regulation01:37

Neural Regulation

40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

394
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Society of Nephrology Commentary on the Evolving Kidney Disease Improving Global Outcomes Adult Glomerulonephritis Guidelines.

Canadian journal of kidney health and disease·2026
Same author

The Role of Renal Denervation in the Treatment of Hypertension in Canada: A Case-Based Discussion from the Canadian Hypertension Specialists Society.

American journal of hypertension·2025
Same author

Insights into Geographic Patterns, Urban-Rural Contrasts, and Health Care Disparities in Glomerular Disease Incidence in a Canadian Province.

Kidney medicine·2025
Same author

Comparing Frailty Assessment Methods and Their Ability to Predict Adverse Outcomes in Patients with Advanced CKD.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids.

Nature communications·2025
Same author

Renal Denervation in Loin Pain Hematuria Syndrome: A Pilot Randomized Controlled Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Deep learning architectures for Parkinson's disease detection by using multi-modal features.

Gunjan Pahuja1, Bhanu Prasad2

  • 1Independent Researcher, Calgary, Alberta, T3J0Z2, Canada.

Computers in Biology and Medicine
|June 6, 2022
PubMed
Summary

This study shows that combining brain imaging and biological data improves Parkinson

Keywords:
AECNNCSFDeep learningMRIPDSPECTSSAE

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

5.1K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

5.1K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Early diagnosis of Parkinson's disease (PD) is critical for effective management and treatment.
  • Delayed diagnosis can negatively impact patient outcomes.
  • Multi-modal feature analysis for PD diagnosis is an area of ongoing research.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of deep learning models using multi-modal features for Parkinson's disease detection.
  • To compare two deep learning frameworks: feature-level and modal-level integration of data.
  • To assess the utility of combining neuroimaging (T1 MRI, SPECT) and biological (CSF) data for PD classification.

Main Methods:

  • Two deep learning frameworks were developed: feature-level and modal-level.
  • The feature-level framework integrated all T1 MRI, SPECT, and CSF features.
  • The modal-level framework used ReliefF to reduce T1 MRI features before integration with SPECT and CSF data.

Main Results:

  • Models achieved high diagnostic accuracy on an imbalanced dataset (73 PD, 59 healthy).
  • The feature-level framework using Convolutional Neural Networks (CNN) reached a maximum accuracy of 93.33%.
  • The modal-level framework using CNN achieved a maximum accuracy of 92.38%.

Conclusions:

  • Multi-modal feature analysis, despite its complexity, is effective for classifying individuals with Parkinson's disease.
  • This approach can significantly aid clinicians in accurate PD diagnosis.
  • Combining diverse data types enhances diagnostic capabilities beyond single-modality approaches.